During coronary angiography for a patient with cardiomyopathy, how can I assess the proportion of ventricular dysfunction attributable to coronary artery disease versus non‑ischemic cardiomyopathy based on the severity, percentage, and location of coronary lesions?

Distinguishing Ischemic from Non-Ischemic Cardiomyopathy During Coronary Angiography

In patients with cardiomyopathy undergoing coronary angiography, you should classify the dysfunction as ischemic cardiomyopathy when there is obstructive coronary disease (≥70% stenosis or ≥50% left main stenosis) in a distribution that corresponds to regional wall motion abnormalities, particularly when two or more adjacent dysfunctional segments align with a coronary territory. 1

Key Angiographic Criteria for Ischemic Cardiomyopathy

Severity and Extent of Coronary Disease

• Obstructive disease is defined as ≥70% diameter stenosis in major epicardial vessels or ≥50% left main stenosis 2
• Ischemic cardiomyopathy typically involves multivessel disease: 71% have triple-vessel disease and 86% have at least one occluded or suboccluded artery 1
• The mean number of diseased vessels in ischemic cardiomyopathy is 2.6 ± 0.7 1
• Stenoses <50% are unlikely to be functionally significant and should not be attributed as the cause of cardiomyopathy 2

Location and Pattern of Disease

• Proximal and mid left anterior descending (LAD) coronary artery lesions are more likely to cause significant ventricular dysfunction due to larger myocardial territory 2
• Proximal circumflex or large obtuse marginal branches 2
• Proximal, mid, or distal dominant right coronary artery 2
• The optimal angiographic cut-off for functionally significant stenosis varies by vessel: 43% for left main and 55% for small vessels 2

Regional Wall Motion Abnormalities

The critical distinguishing feature is the presence of two or more adjacent dysfunctional segments in a vascular distribution 1. This finding has 50% prevalence in ischemic cardiomyopathy versus only 10% in non-ischemic dilated cardiomyopathy 1.

• Regional dyskinesia can occur in both ischemic and non-ischemic cardiomyopathy, but contiguous segmental dysfunction matching coronary territories strongly suggests ischemic etiology 1
• Regional wall motion abnormalities (RWMA) not explained by a culprit lesion suggest non-ischemic cardiomyopathy 2

The Gray Zone: Intermediate Stenoses and Functional Assessment

When Visual Assessment Is Insufficient

For stenoses between 40-90% (or 40-70% for left main), visual angiographic assessment correlates poorly with hemodynamic significance 2. In these cases:

• Only 31% of 40-49% stenoses are hemodynamically significant 2
• Only 35% of 50-70% stenoses are hemodynamically relevant 2
• 20% of 71-90% stenoses are NOT hemodynamically significant 2
• Only stenoses >90% predict hemodynamic relevance with high accuracy (96%) 2

Functional Testing Recommendations

When coronary stenosis severity is intermediate (40-69%), functional assessment with FFR (≤0.80) or iFR (≤0.89) is recommended to determine if the lesion is responsible for ischemia 2. This is particularly important because:

• Diffusely diseased coronary arteries may lead to underestimation of lesion severity due to lack of normal reference segments 2
• Multiple studies show significant interobserver variability in grading stenosis severity 2
• Stenoses considered "insignificant" (<70%) can be hemodynamically significant 2

Mixed or Dual Cardiomyopathy

Approximately 17% of patients with obstructive CAD have coincidental non-ischemic cardiomyopathy (NICM) or dual cardiomyopathy (both ischemic and non-ischemic components) 3. This population has:

• Higher risk of death or heart failure hospitalization compared to pure ischemic cardiomyopathy (adjusted HR 1.23) 3
• Higher risk of all-cause death (HR 1.21) and heart failure hospitalization (HR 1.37) 3
• This may explain why some patients with obstructive CAD do not benefit from revascularization 3

Practical Algorithm for Catheterization Assessment

Step 1: Quantify Coronary Disease

• Identify stenoses ≥70% (or ≥50% left main) 2
• Count number of diseased vessels
• Note location (proximal vs. distal, large vs. small vessels) 2

Step 2: Assess Regional Wall Motion

• Look for two or more adjacent dysfunctional segments 1
• Determine if dysfunction matches coronary territory
• If RWMA is present but doesn't match coronary distribution, suspect non-ischemic or dual cardiomyopathy 2

Step 3: Apply Functional Testing for Intermediate Lesions

• For stenoses 40-90%, perform FFR or iFR to determine hemodynamic significance 2
• Do not assume stenoses 50-70% are causing cardiomyopathy without functional confirmation 2

Step 4: Consider Additional Imaging

When coronary disease doesn't fully explain the degree of dysfunction, cardiac MRI with late gadolinium enhancement (LGE) can distinguish ischemic from non-ischemic patterns 2:

• Subendocardial or transmural LGE in vascular distribution = ischemic 2
• Mid-wall or patchy LGE, particularly at base and mid-septum = non-ischemic 2
• Absence of LGE in 59% of non-ischemic dilated cardiomyopathy 2

Common Pitfalls to Avoid

• Do not assume all cardiomyopathy with CAD is ischemic: 17% have coincidental NICM 3
• Do not rely solely on stenosis percentage: functional significance varies by location and myocardial territory 2
• Do not attribute cardiomyopathy to stenoses <50% unless there is documented ischemia 2
• Do not overlook the pattern of wall motion abnormalities: diffuse global dysfunction with focal CAD suggests dual pathology 1
• Do not forget that perfusion deficits and segmental wall motion abnormalities can occur in non-ischemic cardiomyopathy, making noninvasive testing potentially misleading 2

When Ischemia Has Already Been Excluded

If ischemic cardiomyopathy has already been excluded by prior testing, there is no role for repeat coronary angiography unless clinical status changes to suggest interim development of ischemic disease 2. In these cases, proceed directly to cardiac MRI for tissue characterization rather than repeat angiography 2.